Circulating Proteins Associated with Anti-IL6 Receptor Therapeutic Resistance in the Sera of Patients with Severe COVID-19.

MLA

Michot, Jean-Marie, et al. “Circulating Proteins Associated with Anti-IL6 Receptor Therapeutic Resistance in the Sera of Patients with Severe COVID-19.” Journal of Proteome Research, vol. 23, no. 11, Nov. 2024, pp. 5001–15. EBSCOhost, https://doi.org/10.1021/acs.jproteome.2c00422.

APA

Michot, J.-M., Dozio, V., Rohmer, J., Pommeret, F., Roumier, M., Yu, H., Sklodowki, K., Danlos, F.-X., Ouali, K., Kishazi, E., Naigeon, M., Griscelli, F., Gachot, B., Groh, M., Bacciarello, G., Stoclin, A., Willekens, C., Sakkal, M., Bayle, A., & Zitvogel, L. (2024). Circulating Proteins Associated with Anti-IL6 Receptor Therapeutic Resistance in the Sera of Patients with Severe COVID-19. Journal of Proteome Research, 23(11), 5001–5015. https://doi.org/10.1021/acs.jproteome.2c00422

Chicago

Michot, Jean-Marie, Vito Dozio, Julien Rohmer, Fanny Pommeret, Mathilde Roumier, Haochen Yu, Kamil Sklodowki, et al. 2024. “Circulating Proteins Associated with Anti-IL6 Receptor Therapeutic Resistance in the Sera of Patients with Severe COVID-19.” Journal of Proteome Research 23 (11): 5001–15. doi:10.1021/acs.jproteome.2c00422.